Precigen Inc. (NASDAQ:PGEN) finished Wednesday with an addition of $0.09 to close at $1.68, an upside of 5.66 percent. An average of 2,544,880 shares of common stock have been traded in the last five days. There was a gain of $0.1650 in the past week, and it reached a new high 4 times over the past 12 months. The last 20 days have seen an average of 2,212,495 shares traded, while the 50-day average volume stands at 1,683,812.
PGEN stock has increased by 34.40% in the last month. The company shares reached their 1-month lowest point of $1.0600 on 08/07/23. With the stock rallying to its 52-week high on 01/23/23, shares of the company touched a low of $0.81 and a high of $2.90 in 52 weeks. It has reached a new high 10 times so far this year and achieved 10.53% or $0.1600 in price. In spite of this, the price is down -42.07% from the 52-week high.
Insider Transactions
PGEN stock investors should be aware that Precigen Inc. (PGEN) stock had its last reported insider trading activity 6 days ago on Aug 18. In this transaction, the insider spent $92,719. Chief Legal Officer, Lehr Donald P., disposed of 10,762 shares at a price of $1.55 on Aug 17. The insider now owns more than $16,681 worth of shares. Prior to that, Chief Financial Officer Thomasian Harry Jr. went on to Sale 8,893 shares at $1.55 each on Aug 17. An amount of $13,784 was transacted.
Valuation Metrics
Precigen Inc. (PGEN) stock’s beta is 1.86. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 20.75, the price-to-book (PB) ratio at 2.51.
Financial Health
Further, the company has a long term debt to equity ratio of 0.00 and a total debt to equity ratio of 0.00 for the quarter ending June 29. Precigen Inc.’s EBITDA margin for the year ending June 29 is -250.53%. Its gross profit as reported stood at $20.57 million compared to revenue of $26.91 million.
For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Precigen Inc.’s return on assets was 9.60%.
Earnings Surprise
In the quarter under review, the net income was down than the previous quarter. The company posted a net income of -$20.32 million in the quarter, while revenues of -$22.73 million were grew 13.19%. The analyst consensus anticipated Precigen Inc.’s latest quarter earnings to come in at -$0.1 per share, but it turned out to be -$0.08, a 20.00% surprise. For the quarter, EBITDA amounted to -$19.92 million. Shareholders own equity worth $255.48 million.
Technical Picture
From a technical analysis perspective, let’s take a brief look at Precigen Inc. (PGEN) price momentum. RSI 9-day as of the close on 23 August was 65.75%, suggesting the stock is Neutral, with historical volatility in this time frame at 98.71%.
As of today, PGEN’s price is $1.6420 +10.89% or $0.1650 from its 5-day moving average. PGEN is currently trading +32.28% higher than its 20-day SMA and +66.34% higher than its 100-day SMA. However, the stock’s current price level is +32.28% above the SMA50 and -1.18% below the SMA200.
The stochastic %K and %D were 75.06% and 74.91%, respectively, and the average true range (ATR) was 0.1610. With the 14-day stochastic at 82.12% and the average true range at 0.1494, the RSI (14) stands at 64.00%. The stock has reached 0.0206 on the 9-day MACD Oscillator while the 14-day reading was at 0.1535.
Analyst Ratings
JP Morgan launched coverage on Precigen Inc. (NASDAQ: PGEN) in its analyst report released on May 23, 2023. The firm assigned the stock a Neutral rating. The consensus rating for Precigen Inc. (PGEN) among analysts is Buy. According to current brokerage recommendations, 0 brokerage firms advise that investors sell PGEN, while 1 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 4 others rate it as a “buy”.
What is PGEN’s price target for the next 12 months?
Analysts predict a range of price targets between $6.00 and $14.00, with a median target of $9.00. Taking a look at these predictions, the average price target given by analysts for Precigen Inc. (PGEN) stock is $9.50.
